Zobrazeno 1 - 10
of 99
pro vyhledávání: '"Geir Olve Skeie"'
Publikováno v:
Frontiers in Human Neuroscience, Vol 13 (2019)
Damage to the orbitofrontal cortex (OFC) often occurs following a traumatic brain injury (TBI) and can lead to complex behavioral changes, including difficulty with attention and concentration. We investigated the effects of musical training on patie
Externí odkaz:
https://doaj.org/article/9074067e843d4c4aaf5daad65cbe8fb3
Publikováno v:
PLoS ONE, Vol 14, Iss 9, p e0221752 (2019)
Previous research has demonstrated that people with Parkinson's disease (PD) have difficulties with the perceptual discrimination of rhythms, relative to healthy controls. It is not however clear if this applies only to simpler rhythms (a so called "
Externí odkaz:
https://doaj.org/article/5b984b1f05834864a86716aa676c8cc6
Autor:
Nils Erik Gilhus, Jone F. Owe, Jana Midelfart Hoff, Fredrik Romi, Geir Olve Skeie, Johan A. Aarli
Publikováno v:
Autoimmune Diseases, Vol 2011 (2011)
Patients with autoimmune myasthenia gravis (MG) should be further classified before initiating therapy, as treatment response varies for ocular versus generalised, early onset versus late onset, and acetylcholine receptor antibody positive versus MuS
Externí odkaz:
https://doaj.org/article/7833e1bc504b477db7895e54662fcd48
Autor:
Haakon Berven, Simon Kverneng, Erika Sheard, Mona Søgnen, Solveig Amdahl Af Geijerstam, Kristoffer Haugarvoll, Geir-Olve Skeie, Christian Dölle, Charalampos Tzoulis
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-13 (2023)
Abstract Nicotinamide adenine dinucleotide (NAD) replenishment therapy using nicotinamide riboside (NR) shows promise for Parkinson’s disease (PD) and other neurodegenerative disorders. However, the optimal dose of NR remains unknown, and doses exc
Externí odkaz:
https://doaj.org/article/93fb9663487c47aca79748e329682652
Autor:
Torbjørn Austveg Strømsnes, Morten Lund-Johansen, Geir Olve Skeie, Geir Egil Eide, Maziar Behbahani, Bente Sandvei Skeie
Publikováno v:
Neuro-Oncology Practice. 10:238-248
Background There is no consensus on the management of incidental meningiomas. The literature on long-term growth dynamics is sparse and the natural history of these tumors remains to be illuminated. Methods We prospectively assessed long-term tumor g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::375b888a53bf07b10afee389b86b16a5
https://doi.org/10.1093/nop/npac088
https://doi.org/10.1093/nop/npac088
Autor:
Sunniva Ulstein Kayser, Wolfgang Schmid, Minna Hynninen, Geir Olve Skeie, Karsten Specht, Kristine Madsø, Linda Røyseth Lohne
Publikováno v:
F: Clinical studies: case reports, observational studies and trials.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a9d493c3a938797ec54c2a9b3953a35e
https://doi.org/10.1136/jnnp-2022-ehdn.140
https://doi.org/10.1136/jnnp-2022-ehdn.140
Autor:
Neil Ramsay, Angus D. Macleod, Guido Alves, Marta Camacho, Lars Forsgren, Rachael A. Lawson, Jodi Maple-Grødem, Ole-Bjørn Tysnes, Caroline H. Williams-Gray, Alison J. Yarnall, Carl E. Counsell, Caroline Williams-Gray, null Rachael A Lawson, S. Guido Alves, Lars Forgren, Robert Caslake, Kate S.M. Taylor, David J.M. McGhee, Joanna Gordon, Clare Harris, Hazel Forbes, Roger A. Barker, Thomas Foltynie, Sarah L. Mason, Gemma Cummins, Jonathan R. Evans, David P. Breen, Ruwani S. Wijeyekoon, Jan Linder, Mona Edström, Jörgen Andersson, Linda Eriksson, David Bäckström, Gun-Marie Hariz, Magdalena Domellöf, Michaela Dreetz Gjerstad, Kenn Freddy Pedersen, Elin Bjelland Forsaa, Veslemøy Hamre Frantzen, Anita Laugaland, Johannes Lange, Karen Simonsen, Eldbjørg Fiske, Ingvild Dalen, Bernd Müller, Geir Olve Skeie, Marit Renså, Wenche Telstad, Aliaksei Labusau, Jane Kastet, Ineke HogenEsch, Marianne Kjerandsen, Liv Kari Håland, Karen Herlofson, Solgunn Ongre, Siri Bruun, David Burn, Lynn Rochester, Gordon W. Duncan, Tien K. Khoo
Publikováno v:
Parkinsonism & Related Disorders. 76:49-53
Functional dependency in basic activities of daily living (ADLs) is a key outcome in Parkinson's disease (PD). We aimed to define dependency in PD, using the original and MDS versions of the Unified Parkinson's Disease Rating Scale (UPDRS).We develop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d47d359a7be5ccd18b56052af0ab06a5
https://doi.org/10.1016/j.parkreldis.2020.05.034
https://doi.org/10.1016/j.parkreldis.2020.05.034
Autor:
Brage Brakedal, Christian Dölle, Frank Riemer, Yilong Ma, Gonzalo S. Nido, Geir Olve Skeie, Alexander R. Craven, Thomas Schwarzlmüller, Njål Brekke, Joseph Diab, Lars Sverkeli, Vivian Skjeie, Kristin Varhaug, Ole-Bjørn Tysnes, Shichun Peng, Kristoffer Haugarvoll, Mathias Ziegler, Renate Grüner, David Eidelberg, Charalampos Tzoulis
Publikováno v:
e6
Cell Metabolism
Cell Metabolism
We conducted a double-blinded phase I clinical trial to establish whether nicotinamide adenine dinucleotide (NAD) replenishment therapy, via oral intake of nicotinamide riboside (NR), is safe, augments cerebral NAD levels, and impacts cerebral metabo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aea8272a2d31fe87487f13a5dbbd2f7c
https://hdl.handle.net/11250/3001023
https://hdl.handle.net/11250/3001023
Publikováno v:
Neuro Oncol
The use of stereotactic radiosurgery (SRS) for brain metastases are increasing. Response assessment is challenging and the clinical significance of radiological response and retreatments are poorly defined. Ninety-seven patients with a total of 406 b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::186b9a289c479cbf30a55f508a03cf24
https://europepmc.org/articles/PMC8598792/
https://europepmc.org/articles/PMC8598792/
Autor:
Paal-Henning Pedersen, Geir Egil Eide, Jonathan P.S. Knisely, Bente Sandvei Skeie, Per Øyvind Enger, Geir Olve Skeie, Jan Ingemann Heggdal
Publikováno v:
Neuro-oncology Advances
vdaa026
Neuro-Oncology Advances (NOA)
vdaa026
Neuro-Oncology Advances (NOA)
Background A major challenge in the follow-up of patients treated with stereotactic radiosurgery (SRS) for brain metastases (BM) is to distinguish pseudoprogression (PP) from tumor recurrence (TR). The aim of the study was to develop a clinical risk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::667d46f797bdaba3d595daad07224980
https://pubmed.ncbi.nlm.nih.gov/32642686
https://pubmed.ncbi.nlm.nih.gov/32642686